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Background/aim: The aim of this study was to evaluate and determine the relationships (if any) among pain, depression levels, fatigue,
sleep quality, and quality of life in patients with rheumatoid arthritis (RA) aged 65 years and over, and to compare the results with those
of RA patients under 65 years of age.
Materials and methods: The study included 52 patients with RA aged 65 years and over (Group 1) and 84 patients with RA under
65 years of age (Group 2). Pain, depression levels, fatigue, sleep quality, quality of life, and disease activity of all of the participants
were evaluated using a visual analog scale (VAS), the Beck Depression Inventory (BDI), the Checklist Individual Strength (CIS), the
Pittsburgh Sleep Quality Index (PSQI), the Short Form-36 (SF-36), and the Disease Activity Score-28, respectively.
Results: When the two groups were compared, higher scores for the VAS, BDI, total CIS, and PSQI were found in Group 1 compared
to Group 2 (P = 0.003, P = 0.003, P = 0.007, and P = 0.001, respectively). The SF-36 subscales of the physical component summary and
mental component summary were not statistically significantly different between the two groups (P > 0.05).
Conclusion: This study evaluated the situation in elderly patients with RA and showed that pain, depression level, fatigue, and sleep
quality worsen with age.
Key words: Rheumatoid arthritis, age, depression level, fatigue, sleep quality

1. Introduction
Rheumatoid arthritis (RA), an autoimmune disease of
unknown etiology with systemic symptoms, especially
involves joints and progresses with deformations (1). It has
been reported that the prevalence of RA ranges from 0.5%
to 1%. The disease is two to three times more common in
women than in men (2).
As RA is a disease with systemic involvement,
pain, increased depression level, and fatigue, as well as
deteriorated quality of sleep and life, frequently accompany
the involvement of the musculoskeletal and extraarticular
systems (3–9). Pain is a frequent symptom in RA patients,
and it generally progresses as chronic pain (3). Although its
etiology is not exactly known, it is considered that fatigue in
patients with RA is related to pain, disability, inflammation,
psychosocial factors, and sleep disorders (6). Depression,
also frequent in RA, has been found to be related to the level
* Correspondence: ilknurftr@gmail.com

of fatigue and sleep disorders (7,10). Difficulty in falling
asleep, increased frequency of waking during the night, and
deteriorated sleep quality have been detected in patients
with RA (8). It has been found that deteriorated sleep
quality is related to pain, fatigue, and depression level (1).
Pain, fatigue, and deteriorated sleep quality also negatively
affect the quality of life of RA patients (9).
As has been reported, pain, increased depression
level, fatigue, and deteriorated quality of sleep and life
are frequent complaints in patients with RA, and these
symptoms all affect and worsen each other. Various
studies have evaluated these parameters in patients with
RA, generally focusing on young populations. However,
there are relatively few studies evaluating these symptoms
in patients 65 years of age and over. Therefore, it would not
be correct to generalize the results of these studies for all
patients with RA, especially those aged 65 years and over.
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Given that life expectancy is now extended, knowing
the frequency and severity of these parameters in patients
aged 65 years and over is increasingly important for
physicians in the treatment and follow-up of the disease. As
such, the aim of this study was to evaluate and determine
the relationships (if any) among pain, depression levels,
fatigue, sleep, and quality of life in RA patients aged 65
years and over, and to compare the results with those of
RA patients under 65 years of age.
2. Materials and methods
2.1. Subjects
This study was conducted at a department of rheumatology
from July 2013 to January 2014. Fifty-two subjects aged
65 years and over and 84 subjects under 65 years of age,
all diagnosed with RA according to the American College
of Rheumatology 2010 criteria, were enrolled in the study
by a rheumatologist (11). The patients were tested for 1-h
erythrocyte sedimentation rate, C-reactive protein, complete
blood count, renal and hepatic functions, rheumatoid factor,
and thyroid function. Patients younger than 18 years;
patients whose pain severity was 8 or more according to a
visual analog scale (VAS) (12); patients with a pathology that
could lead to joint pain, such as a fracture, joint dislocation,
acute strain, or sprain; patients with inflammatory rheumatic
diseases other than RA; patients who did not adhere to
the RA drug therapy; patients taking antidepressants or
anxiolytics; patients taking drugs that could affect sleep
quality; patients with hypothyroidism; pregnant patients;
patients with a history of stroke or malignancy; and patients
with cognitive dysfunction who could not complete the
study were excluded. Approval of the local ethics committee
was provided. All of the participants were informed about
the study and provided written consent.
2.2. Data collection
The age, sex, body mass index (BMI), working status,
medical comorbidities, and current medications of all
of the participants were recorded, as was duration of the
disease. The participants were instructed not to exercise
24 h before the second visit, so as not to influence the
VAS, Checklist Individual Strength (CIS), Pittsburgh
Sleep Quality Index (PSQI), and Disease Activity Score-28
(DAS-28) scores.
During the second visit, the pain level, depression
level, fatigue level, sleep quality, quality of life, and disease
activity of the participants were evaluated using the VAS,
Beck Depression Inventory (BDI), CIS, PSQI, Short Form36 (SF-36) questionnaire, and DAS-28, respectively. The
results were recorded by a researcher.
2.2.1. Assessment of pain severity
The VAS rates the pain of the individual on a 0–10 scale and
is widely used in studies (13,14). Patients were evaluated in
terms of pain with movement during the previous week.
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2.2.2. Assessment of depression level
Depression levels were assessed by the BDI, which
included 21 items with scores ranging from 0 to 3. The
highest possible score is 63 points. The BDI, which is one
of the most commonly used self-rated depression scales,
can be adapted to every age group and is considered highly
reliable (15).
2.2.3. Assessment of fatigue
The CIS is a questionnaire with 20 items that can be scored
on a seven-point Likert scale. The CIS is designed to assess
different dimensions of fatigue: 1) the subjective experience
of fatigue (eight items), 2) reduction in motivation (four
items), 3) reduction in physical activity (three items), and
4) reduction in concentration (five items). A total CIS
score is obtained by summing the scores from the four
dimensions. Higher scores indicate higher levels of fatigue,
more concentration problems, less motivation, and low
levels of physical activity (16,17). The total CIS score was
evaluated in the present study.
2.2.4. Assessment of sleep quality
The PSQI was used for the assessment of sleep quality
over a 1-month period. Nineteen individual items
generated seven component scores, which were summed
to produce a global score with a range of 0 to 21. Higher
scores represented poorer subjective sleep quality. Sleep
disturbance was classified as a PSQI score of >5 (18).
2.2.5. Assessment of quality of life
The SF-36 is a generic health-related quality of life
questionnaire employed to obtain scores for eight subscales,
including physical function, role-physical, role-emotional,
social functioning, general health, mental health, vitality,
and bodily pain. These subscales are combined to form two
higher-order summaries: the physical and mental health
component summaries. Each subscale and each summary
is reported on a 0–100 scale. Higher scores indicate better
health-related quality of life (19).
2.2.6. Assessment of disease activity
Disease activity of RA patients was evaluated using the
DAS-28 (20). For this purpose, tender joint count, swollen
joint count, erythrocyte sedimentation rate, and global
assessment score were used. According to the DAS-28
scores, disease activity was defined to be in remission
(≤2.4), with mild activity (>2.4 to <3.2), or with severe
activity (>5.1).
2.3. Statistical analysis
Data were analyzed using SPSS. Descriptive statistics for
continuous variables are presented in the form of means and
standard deviations, whereas categorical data are presented
as numbers and percentages. Clinical data conforming to a
normal distribution were compared using Student’s t-test.
Nonparametric Mann–Whitney or chi-square tests were
performed to compare sociodemographic and clinical
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measures between the two groups. To determine linear
associations between independent variables, Spearman’s
rho correlation coefficients were calculated. For Spearman’s
rho, correlations from 0 to 0.25 were considered as ‘no
correlation’, 0.25 to 0.50 as a ‘mild/moderate correlation’,
0.50 to 0.75 as a ‘strong correlation’, and 0.75 to 1.00 as a
‘very strong correlation’. We considered a significance level
of P < 0.05 to be statistically significant.
3. Results
Of 155 RA patients who were evaluated for inclusion in the
study, 11 were excluded because they did not complete the
questionnaire and eight were excluded because they did
not want to answer the questions due to time constraints.
Ultimately, the study was completed with a total of 136

patients, including 52 patients aged 65 years or over
(Group 1) and 84 patients under 65 years of age (Group
2). The age ranges were 65–83 years in Group 1 and 23–64
years in Group 2. The demographic characteristics of the
two groups are shown in Table 1.
The median disease duration was 120 months (range:
6–480 months) in Group 1 and 72 months (range: 6–360
months) in Group 2 (P > 0.05). The median DAS-28 scores
were 2.78 (range: 0.54–5.9) in Group 1 and 2.41 (range:
1.3–4.55) in Group 2 (P > 0.05). Comorbid diseases and
medical treatments administered for RA in both groups
are presented in Table 2.
When the two groups were compared, higher scores
for the VAS, BDI (scores above 17 indicated depression),
total CIS, and PSQI were found in Group 1 compared

Table 1. Demographic characteristics of Group 1 and Group 2.

Age, years (mean ± SD)

Group 1
(n = 52)

Group 2
(n = 84)

P-value

67.69 ± 4.33

45.71 ± 10.46

<0.001

Sex

0.244

Female

45 (86.5%)

66 (78.6%)

Male

7 (13.5%)

18 (21.4%)

BMI (mean ± SD)

28.22 ± 4.19

27.54 ± 4.29

Occupation

0.365
0.039

Housewife

42 (80.8%)

54 (64.3%)

Civil servant

4 (7.7%)

21 (25%)

Work requiring physical effort

6 (11.5%)

9 (10.7%)

SD: Standard deviation.
BMI: Body mass index.
Table 2. Comorbid diseases and medical treatment of Group 1 and Group 2.
Group 1
(n = 52)

Group 2
(n = 84)

Comorbid diseases

P-value
<0.001

Diabetes mellitus

6 (11.5%)

5 (5.9%)

Hypertension

17 (32.8%)

5 (5.9%)

Coronary artery disease

1 (1.9%)

1 (1.1%)

Chronic obstructive pulmonary disease

0

1 (1.1%)

No comorbid diseases

28 (53.8%)

72 (86%)

Medical treatment

0.581

DMARD

49 (94.2%)

74 (88.1%)

TNF-alpha blockers

3 (5.8%)

10 (11.9%)

DMARD: Disease-modifying antirheumatic drugs.
TNF: Tumor necrosis factor.
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to Group 2 (P = 0.003, P = 0.003, P = 0.007, and P =
0.001, respectively). The SF-36 subscales of the physical
component summary and mental component summary
were not statistically significantly different between the
two groups (P > 0.05) (Table 3).
The correlation analyses of the data from Group 1 and
Group 2 are presented in Tables 4 and 5.
4. Discussion
In this study, RA patients aged 65 years or over had higher
pain, higher depression level, increased fatigue, and worse
sleep quality in comparison to matched RA patients under
65 years of age; however, there was no significant difference
between the two groups with respect to quality of life.
Pain is a common RA symptom in every age group
and the study by Jakobsson et al. suggested that the
severity of pain increases with advanced age (21).
Depression is another frequent symptom of RA, affecting
more than 25% of patients (22). A study comparing the
depression levels of RA patients aged 65 years or over and
RA patients under 65 years reported a 36.9% frequency
of depression in the older patients, whereas only 16%
of the younger individuals had depressive moods (23).
A study of 713 RA patients conducted by Wolfe and

Hawley detected a higher level of depression in elderly
patients (24). Fatigue is highly frequent in patients with
RA, with the frequency of severe fatigue ranging from
42% to 69% (25). The study by Nicassio et al. suggested
that a model of increased disease activity, low mood, and
poor sleep explains 62% of variance in RA fatigue (26).
Deteriorated sleep quality, another frequent symptom
of RA, is observed in more than half of patients (25,27).
Sleep studies in patients with RA have revealed that
interruptions in sleep are more frequent than changes
in sleep phases. In addition, falling asleep takes longer
for them, they wake up several times during the night
and early in the morning, and they experience daytime
sleepiness (5,28). Sleep difficulties have been in large part
attributed to articular pain, depression, psychosocial
stress and fatigue (29–31). This profile of sleep loss
during part of the night, ubiquitous in those with RA,
may result in a vicious cycle in which sleep disturbance
activates clinical symptoms of mood and pain, which
then contributes to further sleep loss (32). RA negatively
affects the quality of life of patients. A study of RA patients
aged 29–70 years detected extremely poor quality of life
and showed that pain and problems with movements
negatively affected quality of life (33).

Table 3. Comparison of Group 1 and Group 2 based on VAS, BDI, total CIS, PSQI, and SF-36 subscale scores.
Group 1 (n = 52),
mean ± SD

Group 2 (n = 84),
mean ± SD

P-value

VAS

4.42 ± 2.23

3.32 ± 1.92

0.003

BDI

16.44 ± 9.39

12.17 ± 7.24

0.003

Total CIS

94.59 ± 23

82.45 ± 26.42

0.007

PSQI

7.07 ± 4.21

5.01 ± 2.89

0.001

Physical function

46.84 ± 26.50

55.05 ± 26.46

0.011

Role-physical (median, min–max)

0 (0–100)

25 (0–100)

0.178

Bodily pain

52.50 ± 24.80

42.73 ± 20.49

0.014

General health

54.42 ± 9.11

53.09 ± 10.52

0.454

Physical component summary

44.56 ± 12.48

46.74 ± 12.55

0.062

Vitality

53.65 ± 10.39

51.01 ± 11.24

0.173

Social function

45.43 ± 16.23

44.49 ± 13.49

0.716

Role-emotional (median, min–max)

0 (0–100)

33.3 (0–100)

0.075

Mental health

51.61 ± 12.80

52.61 ± 10.50

0.620

Mental component summary

46.81 ± 12.92

49.33 ± 12.77

0.267

SF-36

SD: Standard deviation, VAS: Visual analog scale, BDI: Beck Depression Inventory, CIS: Checklist Individual
Scale, PSQI: Pittsburgh Sleep Quality Index, SF-36: Short Form-36, min: minimum, max: maximum.
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0.476

0.283

0.269

BDI

Total CIS

PSQI

0.054

0.042

0.366

0.568

<0.001 1

0.476

r

0.008

0.329

<0.001 1

0.568

<0.001 0.283

P
0.269

r

PSQI

0.017

1

0.329

<0.001 0.366

0.042

P

Total CIS

0.017

0.008

0.054

P

P

P

–0.433 0.001

r

Role physical

0.508

r

–0.431 0.001

–0.166 0.240

0.280

–0.614 <0.001 –0.613 <0.001 0.345

0.188

0.159

0.311

BDI

Total CIS

PSQI

0.004

0.149

0.087

0.345

0.510

1

0.188

0.510

0.159

r

0.001

0.426

<0.001 1

0.087

P
0.311

r

PSQI

<0.001 1

0.426

<0.001 0.345

0.149

P

Total CIS
P

P

–0.359 0.001

r

0.045

0.012

0.424

r

–0.477 <0.001 –0.418 <0.001 0.500

r

<0.001 0.129

<0.001 0.244

<0.001 0.088

<0.001 0.078

P

0.009

0.002

0.063

0.118

P

0.242

0.025

0.429

0.479

P

General health

0.361

0.424

<0.001 0.260

Bodily pain

–0.556 <0.001 –0.531 <0.001 0.469

–0.179 0.103

r

Role physical

<0.001 –0.576 <0.001 –0.411 <0.001 0.490

0.001

0.004

P

Physical
function

VAS: Visual analog scale, BDI: Beck Depression Inventory, CIS: Checklist Individual Scale, PSQI: Pittsburgh Sleep Quality Index.

1

VAS

r

r

P

BDI

VAS

Table 5. The correlation analyses of the data from Group 2.

r

General health

<0.001 0.219

P

Bodily pain

–0.625 <0.001 –0.681 <0.001 0.503

–0.256 0.067

r

Physical
function

VAS: Visual analog scale, BDI: Beck Depression Inventory, CIS: Checklist Individual Scale, PSQI: Pittsburgh Sleep Quality Index.

1

VAS

r

r

P

BDI

VAS

Table 4. The correlation analyses of the data from Group 1.

P

P

0.068

0.432

0.859
–0.069 0.534

0.020

–0.053 0.635

–0.038 0.704

r

Vitality

0.255

0.111

–0.156 0.268

–0.173 0.219

r

Vitality
P

0.089

0.298

0.208

0.187

0.037

0.126

0.005

r

0.089

0.741

0.254

0.963

P

Social function

0.238

0.147

0.177

–0.027 0.851

r

Social function

0.967

P

P
–0.049 0.730

r

Mental health

0.243

P

0.229

r

0.036

P

Mental health

–0.206 0.143

–0.260 0.063

–0.181 0.100

–0.330 0.002

–0.022 0.840

–0.168 0.126

–0.453 <0.001 –0.343 0.001

0.129

r

Role emotional

–0.113 0.425

–0.430 0.001

–0.478 <0.001 –0.356 <0.001

0.006

r

Role emotional
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This study supported all of the aforementioned studies,
determining that pain, depression level, fatigue, and
deteriorated quality of sleep were negatively affected in RA
patients aged 65 years or over. In this study, the depression
level and deteriorated sleep quality in RA patients aged
65 years or over were 50% and 57.6%, respectively. When
the depression level of elderly people was analyzed, it was
determined that advanced patient age without RA also
increases depression level (34). The depression level and
deteriorated sleep quality are considerably higher in elderly
patients with RA. Assessments of elderly patients with
RA should thus focus on pain complaints, psychological
problems, fatigue, and sleep patterns. It should also be
kept in mind that advanced patient age without RA
also influences depression level. However, there was no
significant difference between the two groups with respect
to quality of life. Although it was expected that a negative
impact on the quality of life would increase as patients with
RA aged and developed musculoskeletal diseases such as
osteoarthritis and other comorbid diseases, the results of
this study can be explained by the fact that patients accept
and get used to this condition over time, considering
their current condition to be good enough. Adaptation
and acceptance on the part of patients also increase the
chances of positive responses to treatment.
It is known that pain, increased depression level,
fatigue, and deteriorated quality of sleep are highly
frequent symptoms of RA, and many studies have shown
that these parameters are interrelated, triggering and
negatively affecting each other. Fatigue associated with RA
is related to pain, inflammation, psychosocial factors, and
sleep disorders, while depression is related to the level of
fatigue and sleep disorders (6,7,10). A study comparing
27 RA patients with healthy controls showed that sleep
loss leads to an increase in the number of painful joints
and severity of joint pain, as well as symptoms such as

fatigue and anxiety (32). The present study also detected
relationships among pain, depression level, fatigue, and
quality of sleep within the two patient groups. Therefore,
evaluation and correct treatment of these variables in
patients with RA will help to end the vicious cycle of
triggering each other and ensure more positive results in
treatment and follow-up.
There are several limitations to this study. First, the
sample size was small, which may limit its applicability.
Second, it was a cross-sectional study with no control
group. Studies including a control group and long followup periods might provide better guidance in terms of
pain, depression level, fatigue, quality of sleep and life,
influencing factors, and their long-term effects. Third,
patients with fibromyalgia were not excluded. The presence
of patients with fibromyalgia may also affect some of the
parameters, such as pain, depression level, fatigue, and
sleep quality. Finally, because the study was conducted
at a single center, it cannot be generalized to the whole
population, thus decreasing the strength of the study.
Due to developments in the treatment of RA, a great
number of patients can live to advanced ages, and the
frequency of RA starting in advanced age increases as
life expectancy increases (35). Treatment and control of
the disease become more complex in elderly RA patients.
Many studies have evaluated pain, depression level,
fatigue, sleep quality, and quality of life in patients with
RA. Unlike most of those studies, which were conducted
with young populations and whose results could not be
generalized to all patients with RA, this study evaluated the
situation in patients aged 65 years or over and showed that
pain, depression level, fatigue, and sleep quality worsen
with age. In other words, the treatment and follow-up of
elderly patients with RA should focus on these parameters.
However, multicenter studies with a greater number of
elderly patients are required for more accurate data.
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